Analyst Research: DUSA Pharmaceuticals, Inc (DUSA.O)
DUSA.O on Consolidated Issue listed on NASDAQ Global Market
1.50USD
18 Dec 2009
1.50USD
18 Dec 2009
Price Change (% chg)
$0.19 (+14.50%)
$0.19 (+14.50%)
Prev Close
$1.31
$1.31
Open
$1.28
$1.28
Day's High
$1.87
$1.87
Day's Low
$1.28
$1.28
Volume
701,436
701,436
Avg. Vol
85,409
85,409
52-wk High
$1.80
$1.80
52-wk Low
$0.88
$0.88
| Name | Age | Since | Current Position |
|---|---|---|---|
| Haft, Jay | 73 | 2008 | Chairman of the Board |
| Doman, Robert | 59 | 2007 | President, Chief Executive Officer, Director |
| Christopher, Richard | 39 | 2005 | Chief Financial Officer, Vice President - Finance |
| O'Dell, William | 62 | 2006 | Executive Vice President - Sales and Marketing |
| Carota, Mark | 53 | 2000 | Vice President - Operations |
© Copyright 2009 Thomson Reuters
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
